Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals, Inc.
Counter Defendant: Abraxis Bioscience, LLC
Case Number: 1:2023cv00033
Filed: April 6, 2023
Court: US District Court for the Northern District of West Virginia
Presiding Judge: Thomas S Kleeh
Nature of Suit: Patent - Abbreviated New Drug Applications (ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on May 26, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
May 26, 2023 Filing 24 REPORT of Rule 26(f) Planning Meeting. (O'Brien, William)
May 26, 2023 Filing 23 CERTIFICATE OF SERVICE by Abraxis Bioscience, LLC for its Rule 26(a)(1) Disclosures. (Taylor, Chad)
May 26, 2023 Filing 22 CERTIFICATE OF SERVICE by Mylan Pharmaceuticals, Inc. (Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)). (O'Brien, William)
May 26, 2023 Filing 21 CERTIFICATE OF SERVICE by Mylan Pharmaceuticals, Inc. (Documents produced on 5.23.23). (O'Brien, William)
May 22, 2023 Filing 20 ANSWER to #17 Answer to Complaint, Counterclaim by Abraxis Bioscience, LLC.(Taylor, Chad)
May 3, 2023 Filing 19 FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 6/2/2023. Rule 26 Meeting Report due by 6/16/2023. Discovery due by 7/3/2023. Signed by Chief District Judge Thomas S Kleeh on 5/3/2023. (snc)
May 2, 2023 Filing 18 Corporate Disclosure Statement by Mylan Pharmaceuticals, Inc. identifying Corporate Parent Mylan, Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals, Inc... (Copland, Gordon)
May 1, 2023 Filing 17 ANSWER to #1 Complaint and Mylan's, COUNTERCLAIM against Abraxis Bioscience, LLC by Mylan Pharmaceuticals, Inc..(Copland, Gordon)
April 25, 2023 Filing 16 NOTICE of Appearance by William J O'Brien on behalf of Mylan Pharmaceuticals, Inc. (O'Brien, William)
April 14, 2023 Opinion or Order Filing 15 ORDER. Granting #8 Motion for Leave to Appear Pro Hac Vice re: Daniel C. Wiesner. Signed by Chief District Judge Thomas S Kleeh on 4/14/2023. (hrc)
April 14, 2023 Opinion or Order Filing 14 ORDER. Granting #9 Motion for Leave to Appear Pro Hac Vice re: Matthew J. Hertko. Signed by Chief District Judge Thomas S Kleeh on 4/14/2023. (hrc)
April 14, 2023 Opinion or Order Filing 13 ORDER. Granting #6 Motion for Leave to Appear Pro Hac Vice re: Andrew S. Chalson. Signed by Chief District Judge Thomas S Kleeh on 4/14/2023. (hrc)
April 14, 2023 Opinion or Order Filing 12 ORDER. Granting #7 Motion for Leave to Appear Pro Hac Vice re F. Dominic Cerrito. Signed by Chief District Judge Thomas S Kleeh on 4/14/2023. (hrc)
April 13, 2023 Filing 11 PHV Filing fees for attorneys Francis Dominic Cerrito, Daniel Wiesner and Matthew Hertko in the amount of $ 600, receipt number WVNC003677. (hrc)
April 13, 2023 Filing 10 PHV Filing fee for Andrew Chalson received in the amount of $200, receipt number WVNC003676. (hrc)
April 13, 2023 Filing 9 MOTION for Leave to Appear Pro Hac Vice of Matthew Hertko by Abraxis Bioscience, LLC. (Attachments: #1 Attachment List of cases, #2 Proposed Order)(Taylor, Chad)
April 13, 2023 Filing 8 MOTION for Leave to Appear Pro Hac Vice Daniel Wiesner by Abraxis Bioscience, LLC. (Attachments: #1 Proposed Order)(Taylor, Chad)
April 13, 2023 Filing 7 MOTION for Leave to Appear Pro Hac Vice Francis Dominic Cerrito by Abraxis Bioscience, LLC. (Attachments: #1 Proposed Order)(Taylor, Chad)
April 13, 2023 Filing 6 MOTION for Leave to Appear Pro Hac Vice of Andrew Chalson by Abraxis Bioscience, LLC. (Attachments: #1 Proposed Order)(Taylor, Chad)
April 7, 2023 Filing 5 VERIFICATION OF ATTORNEY ADMISSION to Attorneys Andrew Chalson, Daniel Wiesner, F. Dominic Cerrito, and Matthew Hertko. (dk)
April 6, 2023 Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (dk)
April 6, 2023 Filing 2 Corporate Disclosure Statement by Abraxis Bioscience, LLC. (dk)
April 6, 2023 Filing 1 COMPLAINT against Mylan Pharmaceuticals, Inc., filed by Abraxis Bioscience, LLC. Filing Fee $402. Receipt #AWVNDC-3686212. (Attachments: #1 Exhibit A - US Patent 7,820,788 B2, #2 Civil Cover Sheet) (dk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the West Virginia Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Abraxis Bioscience, LLC
Represented By: Andrew S. Chalson
Represented By: Chad L Taylor
Represented By: Daniel C. Wiesner
Represented By: F. Dominic Cerrito
Represented By: Frank E. Simmerman, Jr.
Represented By: Frank Edward Simmerman, III
Represented By: Matthew J. Hertko
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals, Inc.
Represented By: William J O'Brien
Represented By: Gordon H. Copland
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?